Vaccines and the Infectious Diseases They Prevent

Image representing the teeth of a bat with IMOVAX RABIES and IMOGRAM RABIES-HT writen below

Indications and Usage

IMOVAX Rabies vaccine is indicated for pre-exposure vaccination and post-exposure treatment of rabies^1,2

Pre-exposure vaccination is for people who, because of their jobs or travel destinations, are in danger of exposure to the rabies virus^2,3

Post-exposure treatment is necessary for everyone who even suspects that he or she has come in contact with a rabid animal, whether he or she has had pre-exposure vaccination or not²

As with any vaccine, vaccination with a rabies vaccine or rabies immune globulin may not protect 100% of individuals

Image of chart representing who needs Rabies Protection

Find out more about rabies vaccination schedules NOW!

View full Prescribing Information for IMOVAX Rabies vaccine.

References: 1. IMOVAX Rabies Vaccine Prescribing Information, December 2005. 2. Centers Disease Control and Prevention (CDC). Human rabies prevention—United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1999;48:1-21. 3. CDC. Travelers’ Health: Rabies. Available at: http://www2.ncid.cdc.gov/travel/yb/utils/ybGet.asp?section=dis&obj=rabies.htm. Accessed February 22, 2007.

IMOVAX® Rabies

Indication

IMOVAX Rabies vaccine is indicated for active, pre- and post-exposure immunization against rabies.

Safety Information
The most common local and systemic adverse reactions to IMOVAX Rabies vaccine may include injection site pain, erythema, and swelling; headache, nausea, and muscle aches. Other adverse reactions may occur. Once initiated for post-exposure treatment rabies vaccination should not be interrupted or discontinued because of mild local or systemic adverse reactions. Usually such reactions can be successfully managed with anti-inflammatory and antipyretic agents. Vaccination with IMOVAX Rabies vaccine may not protect all individuals.

Before administering IMOVAX Rabies vaccine, please see accompanying full Prescribing Information.

IMOGAM® Rabies–HT

Indication
IMOGAM Rabies-HT immune globulin is given for passive immunization of individuals suspected of exposure to rabies.

Safety Information
Side effects to the IMOGAM Rabies-HT immune globulin include injection site tenderness, pain, and muscle soreness or stiffness. Other side effects may occur. IMOGAM Rabies-HT immune globulin should not be given in repeated doses once vaccine treatment has begun. IMOGAM Rabies-HT immune globulin is made from components of human blood and, therefore, this vaccine may carry a risk of transmitting infectious material, although careful selection of donors and extensive testing are intended to minimize this risk. Treatment with a rabies immune globulin may not protect all individuals.

For more information about IMOGAM Rabies-HT immune globulin, talk to your health-care professional.

Last modified: 5/2/08